
姓名:南欣榮 性別:男政治面貌:中共黨員
學(xué)歷:研究生學(xué)位:碩士職稱(chēng):主任醫(yī)師,、教授
博,、碩導(dǎo)師:博士生導(dǎo)師本崗位工作年數(shù):38年
研究方向:口腔頜面-頭頸部腫瘤
榮譽(yù)稱(chēng)號(hào):1996年山西省科技進(jìn)步三等獎(jiǎng)、2001年山西省科技進(jìn)步二等獎(jiǎng),、2016年山西省科學(xué)技術(shù)三等獎(jiǎng),、2001年山大一院十佳青年醫(yī)技師、2001年衛(wèi)生系統(tǒng)優(yōu)秀青年崗位能手,、2004年山大一院優(yōu)秀青年專(zhuān)家,、2017年口腔頜面外科科技創(chuàng)新人才
學(xué)術(shù)任職:中華口腔醫(yī)學(xué)會(huì)口腔頜面外科專(zhuān)委會(huì)委員、中華口腔醫(yī)學(xué)會(huì)頜面-頭頸腫瘤專(zhuān)委會(huì)委員,、中國(guó)抗癌協(xié)會(huì)頭頸外科專(zhuān)委會(huì)委員,、中國(guó)醫(yī)師協(xié)會(huì)睡眠醫(yī)學(xué)專(zhuān)委會(huì)委員、中國(guó)康復(fù)醫(yī)學(xué)會(huì)修復(fù)重建外科專(zhuān)委會(huì)委員,、山西省口腔醫(yī)學(xué)會(huì)與山西省口腔醫(yī)師協(xié)會(huì)副會(huì)長(zhǎng),、山西省口腔醫(yī)學(xué)會(huì)口腔頜面外科專(zhuān)委會(huì)主任委員。
近五年承擔(dān)科研課題情況:
1,、山西省應(yīng)用基礎(chǔ)研究計(jì)劃 項(xiàng)目名稱(chēng):尼妥珠單抗聯(lián)合TP術(shù)前誘導(dǎo)化療治療局部晚期口腔癌,、口咽癌的基礎(chǔ)與臨床研究
項(xiàng)目編號(hào):202103021224413
代表性論著及近五年的代表性論文(限10項(xiàng)以?xún)?nèi)):
1、Jin NH,Nan XR, Yan XQ. [Expression and clinical significance of BTG-1 in 78 patients with oral squamous cell carcinoma]. Shanghai Kou Qiang Yi Xue. 2021 Apr;30(2):140-144. Chinese. PMID: 34109351.
2,、Zhao J,Nan X.[Functional evaluation of anterolateral thigh flap and forearm flap for repairing defects after oropharyngeal cancer]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Dec;35(12):1107-1110. Chinese. doi: 10.13201/j.issn.2096-7993.2021.12.010. PMID: 34886625; PMCID: PMC10127646.
3,、閆星泉,南欣榮,任曉彥,等.3D顯微鏡在35例口腔頜面外科手術(shù)中的應(yīng)用效果評(píng)價(jià)[J].中國(guó)口腔頜面外科雜志,2022,20(06):590-593.DOI:10.19438/j.cjoms.2022.06.013.
4、Wang J, Sheng N, Li Y, Fan Y,Nan X, Fu R. Ly6D facilitates chemoresistance in laryngeal squamous cell carcinoma through miR-509/β-catenin signaling pathway. Am J Cancer Res. 2023 May 15;13(5):2155-2171. PMID: 37293155; PMCID: PMC10244118.
5、Sheng N, Fu R, Zhou C, Li Y, Fan Y, Wang J,Nan X. SOX9 promotes stemness in the CAL27 cell line of tongue squamous cell carcinoma. Cell Biochem Funct. 2024 Apr;42(3):e4000. doi: 10.1002/cbf.4000. PMID: 38566395.
6,、Jiang N, Zhao J, Zhou C,Nan X. Circulating interleukin-27 is associated with the risk of chronic periodontitis and allergic rhinitis: A Mendelian randomization analysis. Autoimmunity. 2024 Dec;57(1):2358070. doi: 10.1080/08916934.2024.2358070. Epub 2024 Jun 3. PMID: 38829359.
7,、Li R,Nan X, Li M, Rahhal O. Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinoma. Oncol Res. 2024 Jul 17;32(8):1323-1334. doi: 10.32604/or.2024.046965IF: 2.0 Q3 . PMID: 39055892; PMCID: PMC11267059.
8、Zhou C, Jia H, Jiang N, Zhao J,Nan X.Establishment of Chemotherapy Prediction Model Based on Hypoxia-Related Genes for Oral Cancer. J Cancer. 2024 Aug 13;15(16):5191-5203. doi: 10.7150/jca.96654. PMID: 39247585; PMCID: PMC11375540.
9,、趙佳雄,南欣榮.股前外側(cè)皮瓣與前臂皮瓣修復(fù)口咽癌術(shù)后缺損的功能評(píng)價(jià)[J].臨床耳鼻咽喉頭頸外科雜志,2021,35(12):1107-1110.DOI:10.13201/j.issn.2096-7993.2021.12.010.
10,、田亮亮,南欣榮.NLR對(duì)局晚期口腔鱗狀細(xì)胞癌患者術(shù)前尼妥珠單抗聯(lián)合新輔助化療療效預(yù)測(cè)價(jià)值研究[J].口腔疾病防治,2024,32(05):359-366.